MY101495A - Treatment of diseases caused by viruses - Google Patents

Treatment of diseases caused by viruses

Info

Publication number
MY101495A
MY101495A MYPI87003131A MYPI19873131A MY101495A MY 101495 A MY101495 A MY 101495A MY PI87003131 A MYPI87003131 A MY PI87003131A MY PI19873131 A MYPI19873131 A MY PI19873131A MY 101495 A MY101495 A MY 101495A
Authority
MY
Malaysia
Prior art keywords
cell
virus
inhibitory activity
viruses
treatment
Prior art date
Application number
MYPI87003131A
Inventor
Ueno Ryuzo
Ueno Ryuji
Kuno Sachiko
Hyoshida Osamu
Original Assignee
Kk Ueno Seiyaku Oyo Kenkyujo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kk Ueno Seiyaku Oyo Kenkyujo filed Critical Kk Ueno Seiyaku Oyo Kenkyujo
Publication of MY101495A publication Critical patent/MY101495A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim

Abstract

A PHARMACEUTICAL COMPOSITION FOR TREATING A DISEASE CAUSED BY VIRUS COMPRISING.(A) AN ANTIVIRAL AGENT LACKING INHIBITORY ACTIVITY (1) AGAINST CELL-TO-CELL INFECTION THROUGH CELL FUSION FROM A VIRUS INFECTED CELL TO AN UNINFECTED CELL AND/OR (2) AGAINST ADSORPTION OF A VIRUS TO A TARGET CELL, AND (B) A COMPOUND POSSESSING CELL FUSION INHIBITORY ACTIVITY AND/OR VIRUS-ADSORPTION INHIBITORY ACTIVITY,SAID ANTIVIRAL AGENT AND COMPOUND BEING ADMINISTERED IN RESPECTIVE AMOUNTS SO THAT THE COMBINED DOSAGE THEREOF IS EFFECTIVE TO TREAT SAID DISEASE.
MYPI87003131A 1986-11-29 1987-11-28 Treatment of diseases caused by viruses MY101495A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28581286 1986-11-29
JP14293487 1987-06-08

Publications (1)

Publication Number Publication Date
MY101495A true MY101495A (en) 1991-11-18

Family

ID=26474790

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI87003131A MY101495A (en) 1986-11-29 1987-11-28 Treatment of diseases caused by viruses

Country Status (5)

Country Link
KR (1) KR880005922A (en)
AU (1) AU588493B2 (en)
IL (1) IL84541A0 (en)
MY (1) MY101495A (en)
OA (1) OA10207A (en)

Also Published As

Publication number Publication date
IL84541A0 (en) 1988-04-29
KR880005922A (en) 1988-07-21
AU588493B2 (en) 1989-09-14
AU8184887A (en) 1988-06-09
OA10207A (en) 1997-09-19

Similar Documents

Publication Publication Date Title
EP0270317A3 (en) Pharmaceutical compositions for the treatment of diseases caused by viruses
ES541103A0 (en) PROCEDURE FOR OBTAINING A COMPOSITION FOR THE TREATMENT OF VIRAL INFECTIONS
IE45753L (en) Combating virus infections
PT741577E (en) USING THE ALPHA INTERFERENCE SUBTYPE 8 IN THE PREPARATION OF MEDICINES FOR TREATING FIGURE VIRAL INFECTIONS
ATE157257T1 (en) ENHANCEMENT OF SUPPRESSIVE REGULATION OF AUTOIMMUNE DISEASES BY ORAL OR ENTERAL ADMINISTRATION OF AUTOANTIGENS
JPS6425A (en) Medicinal composition for treating hiv infection containing dsrna and reverse transcriptase inhibitor
WO1998004290A3 (en) Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
MY138860A (en) Hiv protease inhibitors.
PT911033E (en) USE OF CONSENSUS INTERFERENCE FOR REDUCING THE SIDE EFFECTS OF TREATMENT WITH INTERFERES IN VIRAL HEPATITIS
UA66744C2 (en) 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections
GEP20002297B (en) Alpha-Substituted Pyrimidine-Thioalhyl and Alkyl-Ether Compounds, Method for Treatment of Individual Infected with the Immunodeficiency Virus
DE68906735D1 (en) PHARMACEUTICAL PREPARATION FOR TREATING VIRUS DISEASES WITH LIVER EXTRACT.
Klein et al. Herpes simplex virus skin infection in hairless mice: treatment with antiviral compounds
ES2105923A1 (en) Compositions containing 5-iodouracil derivatives for the treatment of hepatitis B infections.
DE69003408T2 (en) Sulphated vinyl polymers in preparations for the treatment of retroviral infections.
MY105855A (en) Therapeutic nucleotides.
MY101495A (en) Treatment of diseases caused by viruses
FR2694693B1 (en) Pharmaceutical composition based on flavopereirine and its use in a treatment against the HIV virus.
ES2162862T3 (en) USE OF TIMOSINE TO TREAT HEPATITIS C IN PATIENTS WHO DO NOT RESPOND TO THE INTERFER TREATMENT.
DE3275060D1 (en) Use of beta-(1-adamantyl)-alpha, alpha-dimethylethylamine for the manufacture of a medicament for the treatment of otitis externa in dogs
DE69817381D1 (en) COMPOSITION AND PHARMACEUTICAL PREPARATION THEREOF FOR THE TREATMENT OF HERPES AND RELATED VIRAL INFECTIONS
ATE26267T1 (en) PYRIMIDINE DERIVATIVES, EQUIPPED WITH ANTIVIRAL ACTION.
ES2052579T3 (en) USE OF INTERFERON ALPHA HUMAN RECOMBINANT FOR THE MANUFACTURE OF A MEDICINAL PRODUCT TO TREAT AIDS VIRUSES.
EP0642793A4 (en) Apoptosis inducer.
TW217986B (en) Compositions for the treatment of infection and disease caused by HBV